Memolek (Memantine Hydrochloride)

Memantine works by binding to the NMDA receptor at a site separate from the normal glutamate binding location. This non‑competitive antagonism limits excessive calcium entry into neurons, reducing excitotoxic damage and supporting neuronal function in Alzheimer’s disease.

The appropriate dose of Memolek is determined by the prescribing healthcare professional based on the patient’s clinical condition, age, renal function, and response to therapy. No specific dosing regimen is provided here; the prescriber tailors the regimen to each individual.

Safety data for memantine in pregnancy and lactation are limited. Because potential risks cannot be ruled out, the drug is generally avoided unless the expected benefit justifies the potential hazard. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their physician.

To request Memolek, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will verify trade or institutional credentials before providing pricing, availability, shipping details and any required import documentation.

Memolek (memantine) belongs to the NMDA‑receptor antagonist class, whereas many other Alzheimer’s drugs are cholinesterase inhibitors (e.g., donepezil). Memantine is typically used for moderate to severe disease and works by reducing excitotoxicity, while cholinesterase inhibitors enhance acetylcholine signaling and are often started earlier in the disease course.

Memolek tablets should be stored at ambient temperature, below 25 °C, in the original container to protect them from moisture and light. Keep the product out of reach of children and do not use if the packaging is damaged.

Memolek is taken orally, usually as a tablet swallowed whole with a glass of water. The medication is intended for adult patients and should be taken exactly as prescribed, without crushing or chewing unless specifically instructed by a healthcare professional.

Serious adverse reactions to Memolek can include seizures, severe allergic responses such as anaphylaxis, and hepatic dysfunction. Patients should be monitored for these events, and any signs of severe reaction require immediate medical attention.